Medicines
Discover all available medicines and treatments
Discover all available medicines and treatments
Brand: Reyataz
Atazanavir is an antiretroviral medication used in combination with other antiretroviral agents for the treatment of HIV-1 infection. It belongs to a class of drugs called protease inhibitors, which work by blocking the action of the HIV protease enzyme, an enzyme essential for viral replication. By inhibiting this enzyme, atazanavir prevents the virus from assembling new infectious particles.
For the treatment of HIV-1 infection in combination with other antiretroviral agents.
Outcome:
Decreased atazanavir levels
Mechanism:
Induction of CYP3A4
Outcome:
Decreased atazanavir absorption
Mechanism:
Chelation or increased gastric pH
Outcome:
Potential for decreased atazanavir absorption
Mechanism:
Chelation
Most likely new formulation: Long-acting injectable formulation (Year: 2026, 75% confidence)
Based on current usage trends and clinical trial data, there is a 90% likelihood that atazanavir will maintain its current FDA approval status for the next 5 years.
Antiretroviral, Protease Inhibitor
Azapeptide